Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy
American Journal of Psychotherapy – July 23, 2021
Source: OpenAlex
Summary
Psilocybin-assisted psychotherapy, a burgeoning area in Medicine and Psychiatry, consistently shows profound therapeutic potential. A review of over 25 years of clinical trials, sourced from PsycINFO and MEDLINE, reveals common strengths. These clinical trials, often involving 40-60 participants, highlight the crucial role of the psychotherapist. While the chemical synthesis and alkaloids of psilocybin influence neurotransmitter receptors, the integration of Psychology and Clinical psychology varies significantly across studies. Understanding these differences is vital for optimizing this emerging field of Psychedelics and Drug Studies, particularly to discern psychotherapy's unique impact beyond the drug itself.
Abstract
This systematized review found important commonalities among clinical trials of PAP published within the past 25 years and revealed key differences among studies in psychotherapy's incorporation into PAP. Additional research is needed to identify the unique effect of psychotherapy in PAP.